Credit Suisse analyst Allison Landry lowered her price target for Genesee & Wyoming to $80 from $94 following quarterly results. Although Genesee's 2018 EBIT guidance came in lighter than the analyst had expected, she notes that the benefits of the tight TL market have already begun to materialize in the form of carload conversions and improved core pricing. From an M&A standpoint, Landry points out that management indicated that it is seeing the most opportunities for possible acquisitions in N. America. The analyst reiterates an Outperform rating on the shares.